
Loading, please wait...

Loading, please wait...

India's healthcare sector is currently grappling with a severe medical device supply chain crisis. The ongoing conflict involving Iran has caused a sharp spike in the price of polypropylene. This thermoplastic polymer is a vital raw material for manufacturing syringes, IV bags, and catheter components. Consequently, healthcare providers across the country may soon face significant shortages of these essential medical consumables.
Recent reports indicate that polypropylene prices have risen by over Rs 55 per kg since December. Furthermore, plastic raw material costs surged by 35% in just a few days during March. This unprecedented increase significantly impacts small and medium enterprises, which constitute 90% of the medical device sector. Because these units operate on thin margins, they cannot easily absorb such drastic cost hikes. Therefore, the risk of production shutdowns is becoming a reality for many manufacturers.
In addition to international pressures, domestic energy issues are compounding the problem. Adani Total Gas recently implemented strict gas rationing, limiting supply to 40% of daily contracted quantities for industrial users. Manufacturers of syringes and other critical devices must now pay premium rates for any consumption exceeding this limit. As a result, many producers may switch to expensive alternate fuels like diesel. This shift not only increases production costs but also negatively impacts local air quality.
The medical device supply chain is also suffering from major logistics disruptions in the Middle East. Shipping routes through the Strait of Hormuz are currently under threat, leading to longer lead times and higher freight costs. Consequently, Indian importers face delays for advanced diagnostic equipment and critical components. The industry has urgently requested government intervention, including subsidies on critical inputs and expedited customs clearances. Finally, without immediate action, the rising costs will likely put immense pressure on hospital procurement budgets.
Q1: Why is there a shortage of medical devices like syringes in India?
The shortage is driven by a surge in polypropylene prices due to the Iran war and domestic gas rationing, which restricts manufacturing capacity.
Q2: How does gas rationing affect the healthcare industry?
Gas rationing forces manufacturers to either reduce production or pay significantly higher costs for energy, leading to increased prices for medical consumables like IV bags and syringes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India's medical device industry faces a severe crisis as polypropylene prices surge and gas rationing hits manufacturers, threatening the supply of syringes...
5 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today